Drug profile · INN
methicillin sodium
STAPHCILLIN
methicillin sodium (STAPHCILLIN) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — methicillin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
methicillin sodium (STAPHCILLIN) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Penicillin-binding protein inhibitor
Primary target: Penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methicillin sodium?
methicillin sodium (STAPHCILLIN) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for methicillin sodium?
STAPHCILLIN is a marketed brand name for methicillin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methicillin sodium?
methicillin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.